Regulatory Challenges in the CIS and Russia - TOPRA In CEE WebinarNovember 22, 2023
Meet us at IV All-Russia GMP Conference 2019
It was our honour to participate at Conference IV All-Russia GMP Conference (IV Вcероссийская GMP-Конференция) “GOOD PRACTICES: BRINGING INDUSTRY AND THE WORLD TOGETHER” on 23-25 September.
This year GMP Conference conference was held in Svetlogorsk, Kaliningrad region. The conference annually brings together leading international and Russian experts in the pharmaceutical industry, government representatives, managers and specialists and experts in the field of the quality management system and good manufacturing practice (GMP).
Over 1000 GMP experts from Russia, Asia, Europe, and the USA were discussing actual problems in the Russian and global pharmaceutical markets, as well as the role of good practices in assuring the quality of pharmaceutical production and international cooperation.
The Conference was organized by the Ministry of Industry and Trade of the Russian Federation together with the «State Institute of Drugs and Good Practices».
Inpharmatis provide full-scope Good Manufacturing and Distribution Practice Services to ensure your compliance with the relevant EU and CIS legislation. We were pleased to participate in such a conference where professionals all over the world share experience, discuss topical issues as integration processes in the context of EAEU and challenging issues of GMP inspection in Russia and other countries.
Meet you next year!
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭСNovember 01, 2023
Features of Choosing the Type of PIL RUT in EAEUNovember 01, 2023
PIL Readability User Testing in EAEU Special Autumn OfferOctober 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладышаOctober 24, 2023
PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022